恶性腱鞘巨细胞瘤的MRI表现特征
回顾性分析2004-2024年经病理证实的12例恶性与23例良性腱鞘巨细胞瘤的MRI资料,发现两者在信号、强化及瘤周水肿等方面无显著差异,但恶性者平均最大径更大(8.6±8.4 cm vs 2.8±2.2 cm)、更常见关节外位置、边缘不规则及瘤周血管。
要点
- 恶性与良性腱鞘巨细胞瘤的MRI信号、强化方式及瘤周水肿无显著差异。
- 恶性者平均最大径8.6±8.4 cm,显著大于良性者的2.8±2.2 cm(p=0.036)。
- 关节外位置、边缘不规则及瘤周血管更常见于恶性腱鞘巨细胞瘤。
核心结论
- 尽管良恶性腱鞘巨细胞瘤MRI表现有重叠,但恶性者更可能表现为体积更大、关节外位置、边缘不规则及明显的瘤周血管;部分恶性病例在影像上可能不与滑膜衬里的结构相关。
研究设计与样本
- 经IRB批准的回顾性研究,回顾2004-2024年经病理证实的良性(23例)与恶性(12例)腱鞘巨细胞瘤的MRI资料。
关键影像表现/征象
- 恶性组平均最大径8.6±8.4 cm,良性组2.8±2.2 cm,差异有统计学意义(p=0.036)。
- 关节外位置在恶性组更常见(p=0.009)。
- 边缘不规则在恶性组更常见(p=0.0014)。
- 瘤周血管在恶性组更常见(p=0.0014)。
- T1信号(p=0.57)、T2信号(p=0.46)、T2信号不均匀性(p>0.99)、低T2信号存在(p>0.99)、强化存在(p=0.21)、强化程度(p=0.12)、不均匀与均匀强化(p=0.21)、无强化区存在(p=0.11)、Blooming伪影(p=0.065)及瘤周水肿(p=0.16)在良恶性组间无显著差异。
诊断标准与关键数值
- 恶性组平均最大径8.6±8.4 cm,良性组2.8±2.2 cm(p=0.036)。
- 关节外位置与恶性相关(p=0.009)。
- 边缘不规则与恶性相关(p=0.0014)。
- 瘤周血管与恶性相关(p=0.0014)。
临床应用与阅片要点
- 阅片时需关注肿瘤最大径、是否位于关节外、边缘是否规则及有无瘤周血管,这些特征更常见于恶性腱鞘巨细胞瘤。
- 良恶性腱鞘巨细胞瘤在信号、强化及瘤周水肿方面表现重叠,不能仅凭这些特征鉴别。
- 部分恶性腱鞘巨细胞瘤在影像上可能不与滑膜衬里的结构相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To examine MRI characteristics of malignant tenosynovial giant cell tumors (TSGCTs) and elucidate features to differentiate benign and malignant TSGCTs.
MATERIALS AND METHODS: With IRB approval, the medical record was retrospectively reviewed from 2004-2024 for cases of pathologically-proven benign and malignant TSGCTs evaluated by MRI.
RESULTS: 12 malignant TSGCTs (5F/7M, mean age 48.7 +/- 17.6 years) and 23 benign TSGCTs (13F/10M, mean age 43.7 +/- 18.7 years) were identified. There was no significant difference in age (p=0.45), gender (p=0.63), MRI signal characteristics (T1 signal p=0.57, T2 signal p=0.46, T2 signal heterogeneity p>0.99, presence of low T2 signal p>0.99), type of enhancement (presence of enhancement p=0.21, degree of enhancement p=0.12, heterogenous vs. homogenous enhancement p=0.21, presence of non-enhancing areas p=0.11), blooming artifact (p=0.065), or presence of perilesional edema (p=0.16) between benign and malignant TSGCTs. Four MRI features were more commonly associated with malignant TSGCTs: extra-articular location (p=0.009), irregular margins (p=0.0014), perilesional vessels (p=0.0014), and larger average maximal dimension (8.6 +/- 8.4 cm malignant vs. 2.8 +/- 2.2 cm benign, p=0.036).
CONCLUSION: Although there are overlapping MRI characteristics between benign and malignant TSGCTs, malignant TSGCTs are more likely to exhibit larger size, extra-articular location, irregular margins and prominent perilesional vessels compared to their benign counterparts. Some malignant TSGCTs may not be associated with a synovial-lined structure on imaging.
引用
- Dutta AR, Wenger DE, Thorpe MP, et al. MR Imaging Features of Malignant Tenosynovial Giant Cell Tumors. Acad Radiol. 2025. PMID: 40287291. doi:10.1016/j.acra.2025.04.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。